Table: Brightpath Biotherapeutics - 9-MTH parent results

BrightPath Biotherapeutics Co

14/02/2025 06:40

Feb 14 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2024        Dec 31, 2023      Mar 31, 2025  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               0 mln             0 mln     
                 (+33.3 pct)         (-98.7 pct)       (-31.3 pct)  
  Operating     loss 815 mln        loss 947 mln      loss 925 mln  
  Recurring     loss 812 mln        loss 947 mln      loss 925 mln  
  Net           loss 815 mln        loss 953 mln      loss 927 mln  
  EPS          loss 10.30 yen      loss 15.14 yen    loss 13.08 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T